Open AccessNeoadjuvant, adjuvant and long-term intravenous/intraperitoneal chemotherapy, hyperthermic intraperitoneal chemotherapy, early postoperative intraperitoneal chemotherapy for ovarian cancer
Author(s) -
Evgenia Halkia,
Paul H. Sugarbaker
Publication year - 2017
Publication title -
journal of peritoneum
Language(s) - English
Resource type - Journals
ISSN - 2531-4270
DOI - 10.4081/joper.2017.59
Subject(s) - medicine , ovarian cancer , chemotherapy , stage (stratigraphy) , intraperitoneal chemotherapy , hyperthermic intraperitoneal chemotherapy , oncology , cytoreductive surgery , epithelial ovarian cancer , adjuvant , disease , cancer , adjuvant chemotherapy , surgery , breast cancer , paleontology , biology
Ovarian cancer is commonly diagnosed after dissemination and is accompanied by a poorer overall prognosis. Treatment incorporates a multimodal approach, utilizing various combinations of surgery and chemotherapy. Ultimately, better screening tests are needed for ovarian cancer to help reduce the burden of advanced-stage disease. For those women with advanced-stage tumors, newer therapeutic strategies may help prolong survival and increase the chance for cure. The aim of this study is to review current trends in the treatment of women diagnosed with advanced-stage epithelial ovarian cancer.